This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Claudia Hjørringgaard, PhD
Principal Scientist at Gubra
Speaker

Profile

Claudia Hjørringgaard is a Principal Research Scientist at Gubra.
She obtained her PhD degree in medicinal chemistry from the University of Aarhus, Denmark, in 2011. Since 2011, she has been working with peptide drug discovery in the pharmaceutical industry as research scientist, while also engaging into the IP field working as a patent attorney.
Claudia joined Gubra in 2022 and is currently lead medicinal chemist on several research programs utilizing and advancing the streaMLine platform.

Agenda Sessions

  • Development of Novel Anti-obesity Peptides Using StreaMLine - A Machine Learning-driven Peptide Drug Discovery Platform

    11:15